HRES 1079119th CongressIn Committee
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Standard Summary
Balanced plain-English summary
This resolution recognizes Charcot-Marie-Tooth disease as a significant inherited peripheral nerve disorder affecting about 126,000 Americans and millions worldwide. It notes that the causative gene has not been fully identified and that federal research funding declined in 2022, and it calls for robust funding for CMT research at the National Institute of Neurological Disorders and Stroke.
Key Points
- 1Recognizes Charcot-Marie-Tooth disease and its impact on patients worldwide.
- 2Notes that CMT is inherited and the specific causative gene remains unidentified.
- 3Highlights a decline in federal CMT research funding in 2022.
- 4Calls for robust NIH/NINDS funding for CMT and rare disease research.
Impact Areas
CMT patients and familiesRare disease advocacy groupsNeurological researchersNational Institutes of Health and NINDS
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026